Roche builds on Foundation stake
Roche has continued its so-called personal healthcare strategy by taking full control of a US genomic profiling group.
Switzerland
Private equity to pay up for sports leader
The attraction of the sports betting and sports media rights markets is set to be powerfully reiterated by…
Nestle coffee deal brings short-term upside, but long-term risks
An analyst has made a positive assessment of Nestle’s deal with Starbucks last month, by which Nestle has…
Zurich looks at specific country deals
The chief executive of the giant Swiss insurance company Zurich has powerfully reinforced recent comments by its finance…
Vontobel buy underlines Swiss pressures, but patience is still needed
Investors are expressing the hope that the deal agreed on 24 May by which Vontobel has taken on…
Credit Suisse, UBS explore innovative deal
In a potentially ground-breaking deal which could set a precedent which many others might seek to follow, the…
Tamedia strengthens media foothold
In a move that stands to tighten even further its media foothold in the country, Switzerland’s largest media…
GSK to buy Novartis stake
GlaxoSmithKline has announced this morning that it is to buy Novartis’s 36.5% stake in their consumer healthcare joint…
Lundbeck buy boosts pipeline
Danish pharmaceutical company H Lundbeck has responded to a fall in sales by boosting its pipeline with the…
Swiss bank eyes more asset management deals
Having decided that the division should be a strategic priority for growth, Swiss bank UBS is understood to…
